About TRUXIMA® (rituximab-abbs) | Rheumatoid Arthritis | See Safety Info
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When? - European Medical Journal
Biologicals in rheumatoid arthritis: current and future | RMD Open
Biologics in severe asthma: the role of real-world evidence from registries | European Respiratory Society
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial - The Lancet
Biological Treatments for Rheumatoid Arthritis
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Managing Rheumatic and Immunocompromised Diseases During COVID-19
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When? - European Medical Journal
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2
Sulfasalazine Shortage: What to Do If You Can't Access Azulfidine
Safety of biologic therapy in rheumatoid arthritis | Nature Reviews Rheumatology
Targeted Delivery Platforms for the Treatment of Multiple Sclerosis | Molecular Pharmaceutics
Unresolved issues in biologic therapy for rheumatoid arthritis | Nature Reviews Rheumatology
Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Chemokine receptor CCR1: new target for asthma therapy: Trends in Pharmacological Sciences
Topical nanocarriers for management of Rheumatoid Arthritis: A review - ScienceDirect
U.S. International Trade Commission will investigate AbbVie claims that rival stole secrets - STAT
